zzz-to be deleted-Free Thyroid Cancer Webinar/Call Series Features Expert Speakers
Dear Friends,
We’re excited to invite you to watch and listen to our Free 1-Hour Thyroid Cancer Webinars with Thyroid Cancer Expert Speakers, sponsored by ThyCa: Thyroid Cancer Survivors’ Association, Inc.
Here are the free webinars with direct links to the details and registration for each:
Webinar Library
- Understanding the Afirma Gene Expression Classifier in Testing Thyroid Nodule, with Erik K. Alexander, M.D., Endocrinologist, Dana Farber Cancer Institute and Brigham and Women’s Hospital, Boston, MA.
- Initial and Reoperative Surgery for Thyroid Cancer and Voice, with Gregory Randolph, M.D., Surgeon, Boston Eye and Ear Infirmary, Boston, MA.
- Papillary/Follicular Thyroid Cancer – A Primer with Bryan McIver, M.B., Ph.D., Mayo Clinic, Rochester, MN.
- Papillary/Follicular Thyroid Cancer – Persistent Disease with Steven I. Sherman, M.D., University of Texas M.D. Anderson Cancer Center, Houston, TX.
- Medullary Thyroid Cancer – A Primer with Robert F. Gagel, M.D., University of Texas M.D. Anderson Cancer Center, Houston, TX.
- Medullary Thyroid Cancer – Persistent Disease with Douglas W. Ball, M.D., Johns Hopkins Medical Institutions, Baltimore, MD.
- Anaplastic Thyroid Cancer with Julie Ann Sosa, M.D., M.A., Yale University School of Medicine, New Haven, CT and R. Michael Tuttle, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY.
- Pediatric Thyroid Cancer with Gary L. Francis, M.D., Ph.D., Virginia Commonwealth University, Richmond, VA, and Steven G. Waguespack, M.D., University of Texas M.D. Anderson Cancer Center, Houston, TX.
- Molecular Imaging and Treatment for the Thyroid with Andrei Iagaru, M.D., Stanford School of Medine, Stanford, CA, and Alan Farwell, M.D., Boston Medical Center, Boston, MA.
- Surgery in the Care of Medullary Thyroid Cancer with Jeffrey F. Moley, M.D., Surgeon, Washington University in St. Louis School of Medicine, St. Louis, MO.
- Thyrogen (rhTSH), used in connection with testing and treatment of differentiated thyroid cancer with Bryan R. Haugen, M.D., Endocrinologist, University of Colorado Health Science Center, Denver, CO.
Each seminar brings you the latest information on a thyroid cancer topic, from leading experts in the field. The speakers are all ThyCa Medical Advisors.
Watch and listen free of charge, online from any computer. And help us get this important information out to others. Please tell everyone in your networks about these terrific free opportunities to learn.
Wishing you well with your health,
ThyCa: Thyroid Cancer Survivors’ Association, Inc.
The Free Webinars/Calls
Date: Tuesday, July 19, 2011
Topic: Medullary Thyroid Cancer – Persistent Disease
Speaker: Douglas W. Ball, M.D., Endocrinologist, Johns Hopkins Medical Institutions, ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar.
Program Details:
Speaker: Douglas W. Ball, M.D.
Douglas W. Ball, M.D., Endocrinologist, Johns Hopkins Medical Institutions, Baltimore, Maryland, is a clinician and researcher specializing in Thyroid Cancer, Medullary Thyroid Cancer, and Multiple Endocrine Neoplasia. His laboratory studies mechanisms underlying the neuroendocrine phenotype seen in some human cancers. Dr. Ball is active in developing new therapies for medullary thyroid cancer, and works in this translational research program in collaboration with other researchers and clinicians. Dr. Ball graduated from George Washington University Medical School and completed further training in Internal Medicine and in Endocrinology and Metabolism at the University of Pittsburgh and Johns Hopkins University. He is the author of numerous peer-reviewed medical journal articles and has been a speaker at previous ThyCa educational events. He is a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Date: Friday, July 29, 2011
Topic: Anaplastic Thyroid Cancer:
Speakers: Julie Ann Sosa, M.D., M.A., Yale University School of Medicine, New Haven, CT; ThyCa Medical Advisor; and R. Michael Tuttle, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY; ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar.
Program Details:
Speakers: Julie Ann Sosa, M.D., M.A., , and R. Michael Tuttle, M.D.
Julie Ann Sosa, M.D., M.A., is an Endocrine and Oncologic Surgeon and Associate Professor of Surgery at Yale University School of Medicine, New Haven, Connecticut. She is principal investigator or co-principal investigator of studies of new drug treatments for differentiated thyroid cancer (papillary/follicular), medullary thyroid cancer, and anaplastic thyroid cancer. Following undergraduate education at Princeton University, she received a master’s degree in Human Sciences at the University of Oxford in the United Kingdom and her medical degree from Johns Hopkins University School of Medicine, Baltimore, Maryland. She received postgraduate training at Johns Hopkins Hospital in Baltimore, Maryland, as well as John Radcliffe and Churchill Hospitals, Oxford, England. She is a frequent invited lecturer and course leader/instructor for professional audiences. She is a member of ThyCa”s Medical Advisory Council.
R. Michael Tuttle, M.D. is an endocrinologist at Memorial Sloan-Kettering Cancer Center, New York, New York. He is also Professor of Medicine at the Joan and Sanford I. Weill Medical College of Cornell University in New York, NY. He is an active clinician and researcher specializing in the management of advanced thyroid cancer. He travels extensively both within the US and abroad lecturing on the difficult management issues in thyroid cancer. His research projects in radiation-induced thyroid cancer have taken him from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. He serves on the American Thyroid Association committee that produced the current guidelines for the management of benign and malignant thyroid nodules. He also chaired the National Comprehensive Cancer Network Thyroid Cancer Panel, and served on the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug, and as a consultant. He is a member of ThyCa”s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Date: Tuesday, August 2, 2011
Topic: Papillary/Follicular Thyroid Cancer – A Primer
Speaker: Bryan McIver, M.B., Ph.D., Mayo Clinic, Rochester, MN; ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar.
Program Details:
Speaker: Bryan McIver, M.B., Ph.D.
Bryan McIver, M.B., Ph.D., F.R.C.P., Endocrinologist, is with the Thyroid Group within the Division of Endocrinology at Mayo Clinic in Rochester, Minnesota; this group has more than 40 full-time endocrine specialists. As a consultant in endocrinology, metabolism and nutrition, he has extensive experience treating patients with diseases of the thyroid, specifically those faced with aggressive cancers such as anaplastic thyroid cancer and other advanced thyroid cancers. He also runs a research lab, working on thyroid cancer genetics and on new treatments for patients with thyroid cancer. Dr. McIver has received numerous awards and honors, including the Endocrine Society Mentor Award for Outstanding Research. He graduated Summa Cum Laude in Medical Sciences from the University of Edinburgh in Scotland, received his Ph.D. in Physiology and Biophysics from the University of Vermont; and his M.B. Ch.B. Faculty of Medicine at the University of Edinburgh. He is a member of the American Thyroid Association’s Thyroid Cancer Guidelines Development Group. He is a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Date: Thursday, August 4, 2011
Topic: Medullary Thyroid Cancer – A Primer
Speaker: Robert F. Gagel, M.D., University of Texas M.D. Anderson Cancer Center; ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar.
Program Details:
Speaker: Robert F. Gagel, M.D
Robert F. Gagel, M.D., Endocrinologist, is Director, Division of Internal Medicine, and Professor, Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas M.D. Anderson Cancer Center in Houston, as well as Adjunct Professor at Baylor College of Medicine. A graduate of Ohio State University Medical School, he completed postgraduate training at Tufts-New England Medical Center, Harvard Medical School, and Harvard School of Public Health. He is a frequent faculty member at medical meetings, serves on numerous committees and advisory groups for professional organizations, and has authored hundreds of peer-reviewed journal articles and other publications. His studies have focused on transcriptional regulation of the calcitonin gene. He and his colleagues identified the new variant of MEN2. Dr. Gagel has also been active in studies of the development of strategies for treatment of medullary thyroid cancer. He is a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Date: Tuesday, August 9, 2011
Topic: Papillary/Follicular Thyroid Cancer – Persistent Disease
Speaker: Steven I. Sherman, M.D., University of Texas M.D. Anderson Cancer Center, Houston, TX; ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar.
Program Details:
Speaker: Steven I. Sherman, M.D.
Steven I. Sherman, M.D. Endocrinologist, is Chair of the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas, M.D. Anderson Cancer Center, Houston, Texas, where he is also a Professor. He is also Adjunct Associate Professor of Medicine at Baylor College of Medicine. A Magna Cum Laude graduate of Harvard College, he received his M.D. from Johns Hopkins School of Medicine, followed by internship, residency, and fellowship at Johns Hopkins Hospital, Baltimore, Maryland, and 3 years as a Clinical Associate Physician, National Institutes of Health, Bethesda, Maryland. His research interests include novel therapies for thyroid carcinoma and recombinant human TSH. He is coauthor of the American Thyroid Association Guidelines on Differentiated Thyroid Cancer and a Board Member of the American Thyroid Association. He is also a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Date: Friday, September 9, 2011
Topic: Pediatric Thyroid Cancer
Speakers: Gary L. Francis, M.D., Ph.D., Virginia Commonwealth University, Richmond, VA; ThyCa Medical Advisor, and Steven G. Waguespack, M.D., University of Texas M.D. Anderson Cancer Center, Houston, TX; ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar:
Program Details:
Speakers: Gary L. Francis, M.D., Ph.D., and Steven G. Waguespack, M.D.
Dr. Gary Francis is Professor of Pediatrics, Chair of the Division of Pediatric Endocrinology and Metabolism and Director of the Fellowship Training Program at Children’s Hospital of Richmond, Virginia Commonwealth University in Richmond VA. He has authored more than 60 manuscripts on thyroid cancer in children and is Chair of the American Thyroid Association Taskforce to Develop Treatment Guidelines for Children with Thyroid Cancer. He has recently spoken on this topic to the Pediatric Academic Societies and the Endocrine Society and he is frequently requested as an invited guest speaker to Universities across the US, Canada and Europe. He is a member of ThyCa’s Medical Advisory Council.
Steven G. Waguespack, M.D., Endocrinologist, is an associate professor of internal medicine and pediatrics at the University of Texas M.D. Anderson Cancer Center in Houston. A native of Louisiana, Dr. Waguespack graduated Summa Cum Laude from Loyola University in New Orleans, where he also participated in the presidential scholars honor program. He graduated from the University of Texas-Houston Medical School with honors and pursued training in internal medicine/pediatrics at Indiana University Medical Center in Indianapolis. He completed a combined adult and pediatric endocrinology fellowship at Indiana University and is board certified in both subspecialties. Recognized as one of “America’s Top Doctors for Cancer” in pediatric endocrinology, his major clinical and research interests are thyroid cancer, pituitary tumors, and metabolic bone disease. At M.D. Anderson Cancer Center, Dr. Waguespack provides endocrine care to patients of all ages. He is a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E- mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
|
Another Archived Webinar Click here to watch and listen: Thyroid Imaging and Therapy in_Thyroid Cancer at DiscoverMI This webinar and the DiscoverMI website are sponsored by SNMMI (Society of Nuclear Medicine and Molecular Imaging). ThyCa is partnering with SNMMI in outreach and publicity. |
Date: Wednesday, September 12, 2012, at 1 p.m. ET / 12 Noon CT
Topic: Surgery in the Care of Medullary Thyroid Cancer
Speakers: Jeffrey F. Moley, M.D., Surgeon, Washington University in St. Louis School of Medicine, St. Louis, Missouri. Dr. Moley is a ThyCa Medical Advisor.
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar.
Program Details:
Speaker: Jeffrey F. Moley, M.D.
Jeffrey F. Moley, M.D., is Professor of Surgery at Washington University School of Medicine in St. Louis, Missouri, as well as Chief of the Cancer and Endocrine Surgery Section and Associate Director of the Siteman Cancer Center. His research focuses on clinical trials of novel treatments for thyroid cancer. A graduate of Harvard University and Columbia University College of Physicians and Surgeons, he completed a surgical oncology fellowship at the National Cancer Institute, National Institutes of Health, and residency at Yale-New Haven Hospital, Yale School of Medicine, where he also was Chief Surgical Resident. He is the author of numerous peer-reviewed articles and book chapters. He has been principal investigator on many federally funded research grants and clinical trials. He has been listed in America’s Top Doctors. Dr. Moley is a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D., is with Biogen Idec, biotechnology company. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group, has moderated ThyCa’s first six webinars, and is also involved in developing Medullary Thyroid Cancer content on ThyCa’s web site. She has also represented ThyCa at many medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Date: Monday, September 24, 2012, at 3 p.m. ET / 2 p.m. CT
Topic: Thyrogen (rhTSH), used in connection with testing and treatment of differentiated thyroid cancer (papillary, follicular, and their variants).
Speaker: Bryan R. Haugen, M.D., Endocrinologist, University of Colorado Health Science Center, Denver, Colorado; ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar
Program Details:
Speaker: Bryan R. Haugen, M.D.
Bryan R. Haugen, M.D., Endocrinologist, University of Colorado School of Medicine, is Professor of Medicine and Pathology, as well as Head, Division of Endocrinology, Metabolism & Diabetes, and Chair of Endocrine Neoplasms Research. Dr.Haugen’s clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction, and other endocrine tumors. Dr Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets. Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms. His research group is also actively studying novel regulation of the hypothalamic-pituitary-thyroid axis.Dr. Haugen is President of the American Thyroid Association. He is a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa’s web site. She also represents ThyCa at medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Date: Thursday, January 24, 2013 at 3 p.m. ET / 2 p.m. CT
Topic: Initial and Reoperative Surgery for Thyroid Cancer and Voice
Speaker: Gregory Randolph, M.D., Surgeon, Boston Eye and Ear Infirmary, Boston, MA; ThyCa Medical Advisor
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar
Program Details:
Speaker: Gregory Randolph, M.D.
Gregory Randolph, M.D., is Director of the General Otolaryngology Service and Director of the Thyroid and Parathyroid Surgical Service at Massachusetts Eye and Ear Infirmary, which he joined in 1986. He is also the founder and director of the annual Harvard Thyroid Surgery course. A graduate of Cornell Medical Collage. He has been actively involved in the development and use of recurrent laryngeal nerve (RLN) monitoring during thyroid surgery. He travels internationally to share knowledge about new technology. He has made repeated trips to the Ukraine with the Children’s Chernobyl Project, an organization that provides surgery and treatment to children with thyroid cancer due to radiation exposure. Dr. Randolph is a member of ThyCa’s Medical Advisory Council.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D., is with Biogen Idec, biotechnology company. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group, has moderated ThyCa’s first six webinars, and is also involved in developing Medullary Thyroid Cancer content on ThyCa’s web site. She has also represented ThyCa at many medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.
Webinar/Call 11
Date: Thursday, December 6, 2012, at 1 p.m. ET, for 30 to 60 minutes
Topic: Understanding the Afirma Gene Expression Classifier in Testing Thyroid Nodules
Speaker: Erik K. Alexander, M.D., Endocrinologist, Dana Farber Cancer Institute and Brigham and Women’s Hospital, Boston, Massachusetts
Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor
Use this link to watch and listen to this webinar.
Program Details:
Speaker: Erik K. Alexander, M.D.
Erik K. Alexander, M.D., is an Endocrinologist at Dana Farber Cancer Institute and Brigham and Women’s Hospital, in Boston, Massachusetts. He is also Director of Medical Student Education at Dana Farber Cancer Institute. Dr. Alexander graduated from Northwestern University Medical School, followed by residency and fellowship at Brigham and Women’s Hospital. He participates in clinical research involving thyroid disease and pregnancy, and thyroid nodules & thyroid cancer. He maintains the largest U.S. registry of consecutive thyroid nodules evaluated and aspirated via a multidisciplinary approach, with data from over 6,000 consecutive patients with clinically relevant thyroid nodules. Most recently, Dr. Alexander has led a national, multi-center study validating the Afirma gene expression classifier for thyroid nodule evaluation.
Moderator: Jan Halzel, Pharm.D.
Jan Halzel, Pharm.D., is with Biogen Idec, biotechnology company. She is a co-moderator of ThyCa’s Medullary Thyroid Cancer E-mail Support Group, has moderated ThyCa’s first nine webinars, and is also involved in developing Medullary Thyroid Cancer content on ThyCa’s web site. She has also represented ThyCa at many medical association meetings. She earned her bachelor’s degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa’s Medical Advisory Council.